Day: April 18, 2023

Coop Pank invites shareholders, investors, analysts and other stakeholders to join its investor webinar, scheduled on 20 April 2023 at 9 am (EET). The webinar will be held in Estonian. The webinar will be hosted by the chairman of the board Margus Rink and chief financial officer Paavo Truu, who present the unaudited financial results of the first quarter of 2023. During the webinar all attendees can ask questions. All questions will be answered after the presentation. To join the webinar, you need to register in advance via following link: https://forms.office.com/e/KDVBgm3P8P Registrants will be sent a link to the webinar and a reminder email one hour before the start of the webinar. The webinar will be recorded and published on the company’s website www.cooppank.ee and on our YouTube account. Coop Pank, based on Estonian capital,...

Oslo, 18 April 2023 – DNO ASA, the Norwegian oil and gas operator, will publish its Q1 2023 operating and interim financial results on 11 May 2023 at 07:00 (CET). A videoconference call with executive management will follow at 10:00 (CET). The Company issues below an update on production and sales volumes for the quarter as well as other key financial information that will be further discussed in the earnings call.Volumes (boepd)Gross operated production Q1 2023 Q4 2022 Q1 2022     Kurdistan 94,720 107,822 106,465     North Sea – – –       Net entitlement production Q1 2023 Q4 2022 Q1 2022     Kurdistan 22,691 25,618 26,670     North Sea 14,776 14,976 12,700       Sales Q1 2023 Q4 2022 Q1 2022     Kurdistan 22,691 25,618 26,670     North Sea 15,865 15,152 10,689       Equity...

WISeKey AI Capabilities to Increase Cybersecurity and Performance of Post-Quantum Semiconductors by Assisting in the Design and Optimization Geneva, Switzerland – April 18, 2023: WISeKey International Holding (“WISeKey”, SIX: WIHN, NASDAQ: WKEY), a leading cybersecurity, AI and IoT company, announced today that using AI capabilities to increase the performance of post-quantum semiconductors by assisting in the design and optimization of these materials. AI can be used to simulate and model the behavior of these semiconductors, which can help researchers to identify the most promising materials for use in quantum devices. Post-quantum semiconductors are an important area of research in the field of quantum computing. They offer the potential to improve the performance and security of devices that rely on quantum technologies. AI plays a...

Maxigesic® IV product 4 Rows of Maxigesic® IV at a manufacturing facilityAdditional extractable & leachable data generated by an accredited lab facility located in North America Results analyzed and evaluated by toxicological experts Potential regulatory approval for Maxigesic® IV for the US market before the end of 2023Liège, Belgium –– 18 April 2023 – 7AM CET – Non-regulated information  – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces that its partner AFT Pharmaceuticals (“AFT”) has submitted a response to the Food & Drug Administration (FDA). The US regulatory body had requested this additional data while considering market approval for Maxigesic® IV, a novel, dual mode-of-action non-opioid...

OSLO, NORWAY (18 April 2023) – The annual general meeting of TGS ASA (“TGS” or the “Company”) will be held on 10 May 2023 at the Company’s offices in Askekroken 11, Oslo, Norway at 17:00 (Oslo time). Registration of attendees will begin at 16:30 CET. The notice for the annual general meeting is attached hereto (English and Norwegian), together with relevant appendices. The notice will be sent to all registered shareholders on 18 April 2023. To register your attendance, grant proxy or cast votes electronically in advance through VPS Investor Services, please copy and paste this link into your browser: https://investor.vps.no/gm/logOn.htm?token=3a5d2040eaba35bbf8ca38e0dedf344d8b8a2186&validTo=1686322800000&oppdragsId=20230329VPO5UCU0 (also available on www.tgs.com). The pin code and reference...

Amsterdam, the Netherlands – [04/18/2023] argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will present six abstracts further demonstrating its long-term commitment to the generalized myasthenia gravis (gMG) community during the 75th American Academy of Neurology (AAN) Annual Meeting, which is taking place from April 22-27, 2023 in Boston, MA. The presentations include clinical and real-world efgartigimod data that demonstrate the potential of neonatal Fc receptor (FcRn) blockade in transforming treatment for gMG and other IgG-mediated autoimmune diseases. “Our presentations at AAN will showcase the depth of evidence we are generating in support of the clinical and real-world profile of efgartigimod to address...

INSIDE INFORMATION Patent covers the therapeutic use of a new composite formulation of anti-inflammatory compounds with unique advantages BioSenic’s new formulation lowers the dosage of arsenic trioxide by combining it with copper salts to maintain therapeutic efficacy, with the potential of administration through multiple routes, including intravenous, oral and other novel routes of administration Mont-Saint-Guibert, Belgium, April 18, 2023, 7.00am CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases and cell repair, today announces the issuance of a key new patent entitled ‘Use of metal ions to potentiate the therapeutic effects of arsenic’ (EP3972613) by the European Patent Office (EPO). BioSenic has recently announced the publication of new data...

In Q1 of 2023, AS LHV Group earned EUR 33.1 million in net profit, i.e., EUR 8.7 million more compared to last quarter (+36%) and EUR 20.7 million more compared to yoy (+167%). The return on equity attributable to the shareholders of LHV Group was 30.4% in Q1. Within the quarter, AS LHV Pank earned EUR 37.3 million in net profit. In Q1, AS LHV Varahaldus earned EUR 87 thousand euros in net profit. AS LHV Kindlustus generated a net loss of EUR 450 thousand and LHV UK Limited generated a net loss of EUR 2.5 million in the first quarter. Consolidated income of the Group in Q1 of 2023 was EUR 68.4 million, which is 21% more than in the previous quarter. Out of the income, EUR 55.1 million was net interest income and EUR 11.9 million net fee and commission income. The operating expenses of the consolidation group made EUR 30.6 million in Q1,...

Ad hoc announcement pursuant to Art. 53 LR Basel/Allschwil, Switzerland, April 18, 2023 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial or fungal infections, provided an updated timeline for its New Drug Application (NDA) submission for its antibiotic ceftobiprole to the US Food and Drug Administration (FDA). Basilea estimates that an additional three to six months of preparatory work will be required to ensure that one of its third-party contract manufacturing organizations (CMOs) is ready for inspection by the FDA, which is a prerequisite for an NDA review. Basilea, therefore, now expects to submit the NDA for the three indications of Staphylococcus aureus bacteremia (SAB), acute bacterial skin and skin structure infections (ABSSSI),...

Taylor Transport Signs Binding Purchase Order To Purchase First Glīd Units Salt Lake City, UT, April 18, 2023 (GLOBE NEWSWIRE) — Genesis Electronics Group Announces First Binding Purchase Order Taylor Transport Signs Binding Purchase Order To Purchase First Glīd Units Salt Lake City, UT – April 17, 2023 – Genesis Electronics Group, Inc. (GEGI), the maker of the autonomous road-to-rail patent-pending shipping technology, Glīd, announced that it has signed Its first purchase order with Taylor Transport, of Vancouver, WA. The relationship between Taylor Transport and GEGI has progressed swiftly as the Companies have spent a significant amount of time together building out a solution for Taylor Transport to utilize Glīd’s autonomous vehicles to augment their existing transportation fleet. As previously announced, Taylor Transport’s...